Thomas Flaten Analyst PerformanceSenior Research Analyst at Lake Street CapitalThomas Flaten is a stock analyst at Lake Street Capital focused in the medical sector, covering 16 publicly traded companies. Over the past year, Thomas Flaten has issued 18 stock ratings, including buy and hold recommendations. While full access to Thomas Flaten's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Thomas Flaten's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 6 YearsBuy Recommendations92.00% 23 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution25RatingsDistribution of strong buy, buy, hold, and sell ratings by Thomas Flaten.RatingPercentageCount Strong Buy0.0%0 ratings Buy92.0%23 ratings Hold8.0%2 ratings Sell0.0%0 ratingsOut of 25 total stock ratings issued by Thomas Flaten at Lake Street Capital, the majority (92.0%) have been Buy recommendations, followed by 8.0% Hold.Best & Worst CallsBest Call0000.0%BDSXMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%EVAXFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ16 companiesThomas Flaten, an analyst at Lake Street Capital, currently covers 16 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical15 companies93.8%Manufacturing1 company6.3%Thomas Flaten of Lake Street Capital specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - DRUGS4 companies25.0%MED - BIOMED/GENE4 companies25.0%MED INSTRUMENTS2 companies12.5%MEDICAL INFO SYS2 companies12.5%MEDICAL SERVICES2 companies12.5%IN VITRO, IN VIVO DIAGNOSTIC SUBSTANCES1 company6.3%MED - GENERIC DRG1 company6.3% Thomas Flaten's Ratings History at Lake Street Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRPIDRapid Micro Biosystems5/22/2026Lower Price Target$2.09$7.00Buy$0.0000.00% ROIMDXHMDxHealth5/14/2026Lower Price Target$0.98$5.00Buy$0.0000.00% ROIASRTAssertio5/13/2026Reiterated Rating$23.31$23.50Hold$0.0000.00% ROIASRTAssertio4/9/2026Downgrade$18.03$18.00Hold$0.0000.00% ROIEVAXEvaxion A/S3/9/2026Lower Price Target$3.12$9.00Buy$0.0000.00% ROIIMDXOncocyte2/17/2026Boost Price Target$5.52$12.00Buy$0.0000.00% ROICSTLCastle Biosciences1/12/2026Boost Price Target$41.17$52.00Buy$0.0000.00% ROIDMACDiaMedica Therapeutics1/5/2026Reiterated Rating$7.93Buy$0.0000.00% ROICNTBConnect Biopharma12/1/2025Initiated Coverage$2.77$9.00Buy$0.0000.00% ROICNTBConnect Biopharma12/1/2025Initiated Coverage$2.66$9.00Buy$0.0000.00% ROIMDXHMDxHealth11/13/2025Boost Price Target$4.01$9.00Buy$0.0000.00% ROIPSNLPersonalis11/5/2025Reiterated Rating$7.58$11.00Buy$0.0000.00% ROIEVAXEvaxion A/S10/20/2025Boost Price Target$6.79$11.00Buy$0.0000.00% ROIHROWHarrow9/29/2025Boost Price Target$47.10$70.00Buy$0.0000.00% ROIDERMJourney Medical8/13/2025Boost Price Target$7.33$13.00Buy$0.0000.00% ROIRPIDRapid Micro Biosystems7/28/2025Initiated Coverage$4.08$8.00Buy$0.0000.00% ROIDMACDiaMedica Therapeutics7/18/2025Boost Price Target$3.93$14.00Buy$0.0000.00% ROIAYTUAytu BioPharma7/1/2025Initiated Coverage$2.18$8.00Buy$0.0000.00% ROIOCXOncoCyte5/21/2025Reiterated Rating$3.44$8.00Buy$0.0000.00% ROIBDSXBiodesix5/14/2025Lower Price Target$4.39$40.00Buy$00.0000.00% ROICSTLCastle Biosciences5/6/2025Lower Price Target$16.62$35.00Buy$00.0000.00% ROIOCXOncoCyte3/28/2025Initiated Coverage$3.22$5.00Buy$0.0000.00% ROIAQSTAquestive Therapeutics3/7/2025Lower Price Target$2.65$8.00Buy$0.0000.00% ROIEVAXEvaxion A/S2/4/2025Lower Price Target$3.30$6.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupKeyCorpWall Street ZenMorgan StanleyHSBCUBS GroupBarclaysWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper Sandler Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
